About Proscia
Proscia is a Healthcare company based in Philadelphia (United States) founded in 2014 by Nathan Buchbinder and Coleman Stavish. It operates as a provider of an AI and cloud-based digital pathology solution for cancer diagnosis. Proscia has raised $129.23 million across 8 funding rounds from investors including Avenue Capital Group, TEDCO and ROBO Global. The company has 85 employees. Its website proscia.com draws about 19 thousand monthly visits. Proscia offers products and services including Concentriq Enterprise Pathology Platform, Concentriq AP, and Concentriq AP-Dx. Its focus areas include HealthTech, Clinical Labs IT, Pathology and Image Analysis. Its legal entity is PROSCIA INC. Its competitors include PathAI, Viz.ai, Deepcell, Deciphex and Aignostics and 3 more; 8 of its 8 listed competitors have raised funding.
Company details
Proscias is a cloud-based software platform that clinic management, analysis, access, and collaboration for slide images in digital pathology. The features of the Proscia platform that allow users to improve whole slide image workflows include secure storage, annotation, and collaboration on digital biopsies. The company has developed a digital pathology platform called Concentriq that uses AI technology for computational pathology applications. The company has developed a tool that assists helathacre providers to diagnose cancer cells using image analysis technology.
- Headquarters Philadelphia, United States
- Employees 85
- Founders Nathan Buchbinder, Coleman Stavish
- SectorsHealthcare
- Phone•••• ••••
- Website proscia.com
- Social LinkedIn X
- Legal Name Proscia Inc.
- Total Equity Funding$129.23M (USD)
in 8 rounds
- Latest Funding Round$50M (USD), Series C
Mar 2025
- InvestorsAvenue Capital Group
& 18 more
- Employee Count85
Products & Services of Proscia
Proscia offers a comprehensive portfolio of products and services, including Concentriq Enterprise Pathology Platform, Concentriq AP, and Concentriq AP-Dx.
Platform for AI-driven pathology analysis in medical diagnostics.
Software for digitizing and analyzing anatomic pathology specimens.
AI tool for precise diagnostic use in pathology workflows.
Funding Insights of Proscia
Proscia has successfully raised a total of $129.23M across 8 strategic funding rounds. The most recent funding activity was a Series C round of $50 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $129.23M
- Total Rounds 8
- Last Round Series C — $50M
- First Round $1M
(Jul 2016)
- Investors Count 19
All 8 funding rounds of Proscia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | $50M | Series C | – | Insight Partners, AI Capital | |
| Dec 2023 | $9M | Series C | – | Highline Capital, Triangle Peak Partners | |
| Jun 2022 | $37M | Series C | – | – | |
| Nov 2020 | $23M | Series B | – | Scale Venture Partners | |
| Sep 2018 | $8.3M | Series A | – | Flybridge Capital Partners | |
| May 2017 | $927,200 | Seed | – | – | – |
| Dec 2016 | – | Seed | – | TEDCO | – |
| Jul 2016 | $1M | Seed | – | Emerald Development Managers |
19 investors in total: 19 institutional.
Investors in Proscia
Proscia has secured backing from 19 investors, including venture fund and institutional investors. Prominent investors backing the company include Avenue Capital Group, TEDCO and ROBO Global.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment firm scaling software and technology companies from early to late stages. | – | insightpartners.com | - | |
- | – | ai.vc | - | |
Private equity and VC-based investment firm | – | trianglepeakpartners.com | Palo Alto, United States | |
Diversified investments in distressed debt and securities are managed globally. | 1995 | avenuecapital.com | New York, United States | |
Early-stage venture capital investments are provided by Emerald. | – | emeraldmanagers.com | New York, United States | |
Investment in early-stage startups focusing on healthcare, AI, and industrial technology. | – | fusionfund.com | - | |
- | – | interwoven.vc | - | |
Multi-stage venture capital investments are made in US sectors. | – | razorsvc.com | Reston, United States | |
- | – | gpghealthcare.tcc.mode | - | |
AI-first companies are supported through venture capital investments. | – | aicapital.ai | Luxembourg, Luxembourg |
Investor details for Proscia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Proscia
35 people are tracked at Proscia (22 in leadership, 13 in team); the tracked headcount is 85.
| Name | Role | Group |
|---|---|---|
Nathan Buchbinder | Co-Founder & Chief Strategy Officer | Leadership |
Coleman Stavish | Co-Founder & CTO | Leadership |
Jon Cohen | Head of Corporate Marketing at Proscia | Leadership |
Kellie Burns | Director - Channel Partnerships | Leadership |
Matthew Spott | Director | Leadership |
Jason Maloney | Vice President, Customer Experience | Leadership |
Rohit D'Costa | Sales Director, Clinical, US West | Leadership |
Maria Terry Careaga | Global Sales Operations Director | Leadership |
Greg Hayden | Sales Director - Life Sciences East | Leadership |
Jeni Caldara | Senior Manager, Partner Ecosystem | Leadership |
David West | CEO | Leadership |
Arun Ananthapadmanabhan | Chief Commercial Officer | Leadership |
Stephan Fromme | Head of Strategic Alliances | Leadership |
Tom Gallo | Chief Financial Officer | Leadership |
Juan Ramon Pons Hernandez | Director Desarrollo de Negocio | Leadership |
Amanda C. | Senior Director Of Product | Leadership |
Sydney Fenkell | Head Of Marketing Communications | Leadership |
Nikki J. | Senior Sales Director, Life Sciences, U.S. West | Leadership |
Mary Monzo | Head Of People Operations | Leadership |
James St John | Director of Life Science (EMEA) | Leadership |
15 more people are available in the full profile.
Complete people profiles for Proscia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Proscia
3 dated milestones of Proscia across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Proscia is founded.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Series C, of $50.0M.
Competitors of Proscia
Proscia has 8 listed competitors in our database, 8 of them funded. They include PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pathai.com | 2016 | Boston, United States | $254.94M | 573 | Provider of AI-based solutions for clinical diagnosis of cancer and other diseases | |
| viz.ai | 2016 | San Francisco, United States | $251.99M | 206 | AI and cloud-powered software for stroke care coordination is developed. | |
| deepcell.com | 2015 | Mountain View, United States | $122.99M | 94 | AI-powered single cell classification and isolation technology for clinical research | |
| deciphex.com | 2017 | Dublin, Ireland | $56.65M | – | Digital pathology software is developed for clinical and veterinary productivity. | |
| aignostics.com | 2018 | Berlin, Germany | $53.89M | 25 | AI-based pathology diagnostic software is provided for medical analysis. | |
| pictorlabs.ai | 2019 | Los Angeles, United States | $48.83M | – | AI-based tools for pathological image analysis are provided to labs. | |
| paige.ai | 2018 | New York, United States | $241M | – | AI-enabled tools for computational pathology and cancer diagnostics are provided. | |
| enspectrahealth.com | 2014 | Mountain View, United States | $15.55M | 8 | Developer of medical devices for tissue imagining and cancer detection |
Detailed competitors of Proscia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Proscia
The website of Proscia (proscia.com) receives about 19.3K visits a month.
- Monthly visits19.3K
▼ 1.2% vs previous month
Websites whose visitors overlap most with Proscia. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| thebiomedicalscientist.net | 100% | – | #1,660,355 | View details | |
| lighthouselabservices.com | 98% | 20.9K | #1,380,323 | View details | |
| digitalhealth.net | 92% | 51.1K | #683,994 | View details | |
| aiforia.com | 92% | 25.6K | #946,262 | View details | |
healthcare-in-europe.com | healthcare-in-europe.com | 92% | – | #222,447 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for Proscia
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
10 companies that operate in the same segment as Proscia (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts | 2016 | Bengaluru, Karnataka, India | USD 716.99 M | – | 1,832 | |
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | – | – | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | – | 1,746 | |
Tech-enabled mental health solutions for employers are provided. | 2016 | New York, New York, United States | USD 473.73 M | – | 3,902 | |
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, Ile de France, France | USD 863.12 M | – | 1,606 | |
Virtual care programs for managing chronic diseases are provided. | 2011 | San Francisco, California, United States | USD 450.12 M | USD 260.21 M | 992 | |
AI-driven EMR and practice management software is delivered for clinics. | 2010 | Boca Raton, Florida, United States | USD 329.17 M | – | 2,470 | |
Cloud-based administrative tools for healthcare providers are offered. | 1997 | Watertown, United States | USD 40 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Proscia
Complete news archive for Proscia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Proscia
Proscia was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Proscia is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Proscia is a funded company, having raised a total of $129.23M across 8 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Jul 2016.
Proscia has 85 employees.
Proscias is a cloud-based software platform that clinic management, analysis, access, and collaboration for slide images in digital pathology. The features of the Proscia platform that allow users to improve whole slide image workflows include secure storage, annotation, and collaboration on digital biopsies. The company has developed a digital pathology platform called Concentriq that uses AI technology for computational pathology applications. The company has developed a tool that assists helathacre providers to diagnose cancer cells using image analysis technology.
Proscia's top competitors include Aignostics, Deciphex and Pictor Labs.
Proscia offers Concentriq Enterprise Pathology Platform, Concentriq AP, and Concentriq AP-Dx.
Proscia has 19 investors. Key investors include Avenue Capital Group, TEDCO, ROBO Global, Insight Partners, and AI Capital.
Proscia operates through Proscia Inc..